185 Secukinumab demonstrates consistent safety over long-term exposure in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. (25th April 2018) - McInnes, Iain; Mease, Philip; Reich, Kristian; Nash, Peter; Andersson, Mats; Abrams, Ken; Pricop, Luminita; Fox, Todd